Skip to main content
. 2014 Mar;103(3):496–503. doi: 10.1016/j.diabres.2013.12.036

Table 3.

Comparison of the Saudi IMPACT T2DM Forecast Model against other modelling studies.

Shaw et al. [6] Wild et al. [7] King et al. [8] Amos et al. [9] Saudi IMPACT Diabetes Forecast Model
Estimated DM prevalence in Saudi Arabia (%) 2010 Total: 13.6 2000 Total: 6.2 1995 Total: 8.7 1995 Total: 10.0 1995 Total: 11.1
2030 Total: 17.0 2030 Total: 8.1 2000 Total: 9.1 2000 Total: 12.0 2000 Total: 17.2
2025 Total: 10.1 2010 Total: 13.8 2010 Total: 28.1
2022 Total: 44.1



Age of study population (years) 20–79 20+ 20+ 20+ 25+



Main data sources for DM prevalence in Saudi Arabia Al-Nuaim et al. [31]
El-Hazmi et al. [32]
Al-Nozha et al. [26]
El-Hazmi et al. [32] Asfour et al. [27](Study from Oman) El-Hazmi et al. [33]
Asfour et al. [27](study from Oman)
Warsy and El-Hazmi [17] (for starting year prevalence)
WHO STEPS [12] (for validation)



Estimation methodology Logistic regression modelling DISMOD 2 Age-specific diabetes prevalence estimates were applied to UN population estimates and projections Country-specific diabetes prevalence data were applied to the corresponding national age distribution Markov modelling



Covariates used for estimating DM prevalence • Demographic changes
• Urbanisation
• Demographic changes
• Urbanisation
• Trends in population size and age structure
• Urbanisation
• Level of economic development (GNP per capita)
• Urbanisation
• Trends in population structure
• Trends in obesity prevalence
• Trends in smoking prevalence
• Estimated incidence of T2DM
• Estimated case-fatality rate
• Evidence-based estimates of RRs for transition probabilities